![Light chain deposition disease (pulmonary manifestations) | Radiology Reference Article | Radiopaedia.org Light chain deposition disease (pulmonary manifestations) | Radiology Reference Article | Radiopaedia.org](https://prod-images-static.radiopaedia.org/images/5346029/fb4e83d1dba07df300cd53f28b277b_gallery.jpg)
Light chain deposition disease (pulmonary manifestations) | Radiology Reference Article | Radiopaedia.org
![AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells | Laboratory Investigation AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells | Laboratory Investigation](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Flabinvest.3700161/MediaObjects/41374_2004_Article_BF3700161_Fig15_HTML.jpg)
AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells | Laboratory Investigation
Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease
![Nodular pulmonary light chain deposition disease: an entity associated with Sjögren syndrome or marginal zone lymphoma | Journal of Clinical Pathology Nodular pulmonary light chain deposition disease: an entity associated with Sjögren syndrome or marginal zone lymphoma | Journal of Clinical Pathology](https://jcp.bmj.com/content/jclinpath/69/6/490/F3.large.jpg)
Nodular pulmonary light chain deposition disease: an entity associated with Sjögren syndrome or marginal zone lymphoma | Journal of Clinical Pathology
![Clinicopathological features and outcomes of coexistent light chain cast nephropathy and light chain deposition disease in patients with newly diagnosed multiple myeloma | Journal of Clinical Pathology Clinicopathological features and outcomes of coexistent light chain cast nephropathy and light chain deposition disease in patients with newly diagnosed multiple myeloma | Journal of Clinical Pathology](https://jcp.bmj.com/content/jclinpath/75/10/668/F1.large.jpg)
Clinicopathological features and outcomes of coexistent light chain cast nephropathy and light chain deposition disease in patients with newly diagnosed multiple myeloma | Journal of Clinical Pathology
![The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-019-02147-4/MediaObjects/12967_2019_2147_Fig1_HTML.png)
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
![Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy | American Society of Nephrology Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/1/6/1342/F1.large.jpg)
Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy | American Society of Nephrology
![PDF] Polyclonal free light chains: a biomarker of inflammatory disease or treatment target? | Semantic Scholar PDF] Polyclonal free light chains: a biomarker of inflammatory disease or treatment target? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/091b9510bd72aa951da79457a27309803520cd7e/2-Figure1-1.png)
PDF] Polyclonal free light chains: a biomarker of inflammatory disease or treatment target? | Semantic Scholar
![Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy | American Society of Nephrology Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/1/6/1342/F2.large.jpg)
Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy | American Society of Nephrology
![Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy | American Society of Nephrology Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/1/6/1342/F5.large.jpg)
Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy | American Society of Nephrology
![IgA kappa light and heavy chain deposition disease in multiple myeloma - Sannier - 2018 - British Journal of Haematology - Wiley Online Library IgA kappa light and heavy chain deposition disease in multiple myeloma - Sannier - 2018 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f185cb08-1059-425e-9258-f8c41db1d92d/bjh15420-fig-0001-m.jpg)
IgA kappa light and heavy chain deposition disease in multiple myeloma - Sannier - 2018 - British Journal of Haematology - Wiley Online Library
![Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease - Kidney International Reports Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease - Kidney International Reports](https://www.kireports.org/cms/asset/3eb6461a-aa0f-4e31-b15c-52e37b516907/gr1.jpg)